- Report
- May 2024
- 135 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- August 2024
- 121 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- January 2022
- 141 Pages
France
From €3378EUR$3,712USD£2,896GBP
Anovulation is a condition in which a woman does not ovulate, or release an egg, during her menstrual cycle. It is a common cause of infertility and can be caused by a variety of factors, including hormonal imbalances, polycystic ovary syndrome, and thyroid disorders. Women's health professionals often use a variety of treatments to help women with anovulation, including lifestyle changes, medications, and fertility treatments.
The anovulation market is an important part of the women's health industry, as it provides treatments and services to help women with anovulation. Companies in this market offer a range of products and services, including diagnostic tests, fertility treatments, and lifestyle advice. Examples of companies in the anovulation market include OvaScience, Progyny, and Modern Fertility. Show Less Read more